Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Similar articles for PubMed (Select 18973686)

1.

Adalimumab induced mononeuritis multiplex in a patient with refractory rheumatoid arthritis: a case report.

Makol A, Grover M.

Cases J. 2008 Oct 30;1(1):287. doi: 10.1186/1757-1626-1-287.

2.

Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept.

Marques IB, Giovannoni G, Marta M.

BMC Neurol. 2014 Dec 11;14:237. doi: 10.1186/s12883-014-0237-5.

3.

Granulomatosis with polyangitis with mononeuritis multiplex-immunosuppressives playing a double-edged sword.

Mukherjee S, Biswas D, Begum S, Bhanja P, Misra AK, Chatterjee P.

Lung India. 2014 Oct;31(4):397-400. doi: 10.4103/0970-2113.142143.

4.

Livedoid Vasculopathy and Mononeuritis Multiplex, with a Fulminant Hepatic Failure which was caused by Herpes Simplex Hepatitis: A Case Report.

Pai B S, Pai K.

J Clin Diagn Res. 2013 May;7(5):921-3. doi: 10.7860/JCDR/2013/5775.2977. Epub 2013 Mar 15.

5.
6.

Mononeuritis multiplex due to leprosy: a case of atypical presentation.

Pedraza Hueso MI, Hinojosa Mena-Bernal C, Hernández-Laín A, Guerrero Peral AL.

Neurologia. 2014 Jun;29(5):313-4. doi: 10.1016/j.nrl.2012.10.012. Epub 2012 Dec 28. English, Spanish. No abstract available.

7.

ATT- A Double Edged Sword?

Gude D, Bansal DP.

Indian J Pharm Sci. 2011 Nov;73(6):663-5. doi: 10.4103/0250-474X.100241.

8.

Management of recurrent cutaneous abscesses during therapy with infliximab.

De Simone C, Murri R, Maiorino A, Venier A, Caldarola G.

Clin Ther. 2011 Dec;33(12):1993-6. doi: 10.1016/j.clinthera.2011.10.015. Epub 2011 Nov 14.

PMID:
22088412
9.

Spondylarthritis presenting with an allergic immediate systemic reaction to adalimumab in a woman: a case report.

Benucci M, Manfredi M, Testi S, Iorno ML, Valentini M, Soldaini F, Campi P.

J Med Case Rep. 2011 Apr 19;5:155. doi: 10.1186/1752-1947-5-155.

10.

Adalimumab - an effective and promising treatment for patients with fistulizing Crohn's disease: a case series.

Kouklakis G, Efremidou EI, Zezos P, Liratzopoulos N, Souftas VD, Gatopoulou A, Simopoulos K, Manolas KJ.

J Med Case Rep. 2011 Mar 19;5:109. doi: 10.1186/1752-1947-5-109.

11.

Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease.

Horai Y, Miyamura T, Shimada K, Takahama S, Minami R, Yamamoto M, Suematsu E.

J Clin Pharm Ther. 2012 Feb;37(1):117-21. doi: 10.1111/j.1365-2710.2010.01234.x. Epub 2010 Dec 5. Review.

PMID:
21128990
12.

Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study).

Migliore A, Bizzi E, Massafra U, Vacca F, Martin Martin LS, Ferlito C, Podestà E, Granata M, Laganà B.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):783-90.

PMID:
20943048
13.

Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.

Gifre L, Ruiz-Esquide V, Xaubet A, Gómez-Puerta JA, Hernández MV, Sanmartí R.

Arch Bronconeumol. 2011 Apr;47(4):208-12. doi: 10.1016/j.arbres.2010.05.011. Epub 2010 Jul 17.

14.

Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving infliximab: a case report.

Justice EA, Khan SY, Logan S, Jobanputra P.

J Med Case Rep. 2008 Aug 26;2:282. doi: 10.1186/1752-1947-2-282.

15.

Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.

Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.

Isr Med Assoc J. 2008 Apr;10(4):277-81.

16.

[Vasculitis in rheumatoid arthritis--case report].

Vergles D, Culo IM, Durasević Z, Soldo-Juresa D, Galesić K, Morović-Vergles J.

Reumatizam. 2006;53(1):25-8. Croatian.

PMID:
17580546
17.

Vasculitis following treatment of rheumatoid arthritis with extracorporeal staphylococcal protein a immunoadsorption column (prosorba).

Scroggie D, Harris MD, Abel M, Sakai L, Arroyo R.

J Clin Rheumatol. 2001 Aug;7(4):238-41.

PMID:
17039141
18.

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group.

Arthritis Rheum. 2006 Sep;54(9):2793-806.

19.
20.

Drug-induced lupus after treatment with infliximab in rheumatoid arthritis.

Benucci M, Li Gobbi F, Fossi F, Manfredi M, Del Rosso A.

J Clin Rheumatol. 2005 Feb;11(1):47-9.

PMID:
16357696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk